“showed a trend”

Heel-rise work showed a trend in favor of surgically treated patients ( P = .08).

Old items were also associated with significantly lower confidence than Control items (Agentic Subject: t (17) = 4.30, P = 0.0005; Agentic Experimenter: t (17) = 6.28, P = 0.000008; Conceptual Obama: t (17) = 4.93, P = 0.0001), with the exception of items that the participant had related to themselves during study, which only showed a trend for lower confidence (Conceptual You: t (17) = 1.89, P = 0.08).

The 8-OHdG nucleic acid damage marker was expressed at significantly lower levels in the ethanol-exposed TL-Tx ( p = 0.0074; Figure 7D ), showed a trend-wise increase in the TL-MVs ( p = 0.08; Figure 7E ) from the ethanol-exposed animals, and was unaltered by ethanol in the S-EVs ( Figure 7F ). 3.5.

The CIA/high-dose DCPA treatment group had density indistinguishable from that of untreated controls ( figure 3 D) and showed a trend toward greater density than in CIA/placebo mice (p=0.08).

In contrast, in winter, when RNA:DNA and RNA:MBC ratios did not differ significantly between warmed and non-warmed LTW grassland soils, soil water, and DOC contents were significantly lower in the warmed soils ( P < .05) and total C and N showed a trend towards lower contents in the warmed soils ( P < .08).

The accuracy rate and number of CPR experiences showed a trend of negative association (P=0.08).

The other tested matrix-metalloproteinase MMP9 also showed a trend between these two groups, 0.39 ± 0.21 versus 1.14 ± 0.34 respectively, p < 0.08.

RMG showed a trend to be lower in LP compared to NP (p<0.08) at PND 10 and 12.

Consistently, HPLC determination of 5-HT levels in spinal cord extracts showed a trend toward higher caudal-to-rostral 5-HT concentrations in bPAC animals compared to control (0.51 ± 0.27vs.0.14 ± 0.11 μM/mg protein, respectively; p = 0.08, Mann–Whitney test, Fig. 5G ).

Spliced variant of fibronectin, extra domain A ( ED-A ), showed a trend towards higher mRNA expression in the mucosa of IFX failure patients compared to IFX naïve patients (p = 0.08).

The second germline DMR, the Nespas DMR, also showed a trend towards loss of imprinting during gametogenesis in both oocytes and spermatozoa (30.67 ± 1.54% in FD group vs. 35.00 ± 1.74% in controls for oocytes, P = 0.08; 2.71 ± 0.39% in FD groups vs. 5.28 ± 1.65%, in controls for spermatozoa, P = 0.08) (Figure 3 ).

Injury assessment with the composite neuroscore showed a trend for impairment nine days post-injury (t(22) = 1.8, p = 0.08), although our previous study using this found no significant effect of bTBI 44 .

In the experimental treatment versus bevacizumab subgroup, all studies failed to show a significant improvement of PFS, although HDAC‐inhibition with vorinostat and bevacizumab 37 showed a trend towards prolonged PFS (RR 0.63, 95% CI 0.37–1.06; p = 0.08; n = 85).

Moreover, Reference frame showed a trend towards more negative FRN amplitudes for non-social than social trials [T WJt /c(1.0, 46.5) = 3.27, P = 0.080].

For the prime movers, the lateral gastrocnemius (LG) showed a trend toward less activity in the VL pedals than the LAT pedals, with an 8.4 ± 4.5% lower activation (mean ± SE; p = .080).

When transferred to HFD, by contrast, the VSG group on anti-GLP1R antibody (Ab) paradoxically ate significantly more than VSG mice given isotype control and showed a trend toward additional weight gain (p = 0.08 versus VSG controls) ( Figures 2 A, 2B, 2C, and 2F), suggesting that endogenous GLP-1 suppressed intake of HFD despite having little effect on ingestion of the liquid diet.

Comparing to sham, the mitochondrial respiration with GM showed a trend toward altered State III respiration (42%, p = 0.08, non-significant), whereas State V respiration was reduced significantly (62%, * p < 0.05) in the PBBI group.

While 90-day mortality showed a trend toward higher rates in transfused patients (2.4%, n=41 vs 0.5%, n=354), this difference did not reach statistical significance (p=0.08).

At admission, patients with ACE showed significantly higher serum levels of neopterin compared to those with no ACE (79.16 ± 20.31 nmol/L vs 47.47 ± 17.83 nmol/L, P = .01), while hsTroponinT only showed a trend toward higher levels in patients with ACE (71.50 ± 54.72 ng/L vs 33.24 ± 15.63 ng/L, P = .08).

Children with bacterial airway colonization at age 4 weeks compared with noncolonized children showed a trend of increased hs-CRP levels (2.68 mg/L [IQR, 0.84-5.17 mg/L] vs 1.31 mg/L [IQR, 0.49-4.64 mg/L], P = .08).

MPAAQ The Mann-Whitney U test showed a trend (U = 36322, p = 0.08) showing that women (MED = 32; IQR = 17) scored higher than men (MED = 30; IQR = 17) in the MPAAQ.

Active individuals with uncontrolled BP levels showed a trend (p = 0.08) of 17% higher risk of all-cause mortality compared to their peers with controlled BP levels.

In a post hoc analysis of patients in advanced stage, a significant PFS advantage was observed in patient who had received ibrutinib ( P = 0.03), who showed a trend for OS advantage ( P = 0.08).

The assessment of lipid oxidative damage showed a trend of greater values in control newborns than in treated ones ( p = 0.08), but similar values of the antioxidant capacity.

Compared with the Control and LP groups, the CP group showed a trend for increased osteoblasts (control group, 15.09 cells/mm 2 ; LP group, 18.55 cells/mm 2 ; CP group, 25.44 cells /mm 2 ; control vs CP, p = 0.08; LP vs CP, p = 0.33) in the cranial, middle, and caudal areas as well as the entire bone.